Sex ratio and rheumatic disease.

Abstract:

:Some thyroid, rheumatic and hepatic diseases consistently have high female:male ratios, but many autoimmune diseases do not. Gonadal hormones, if they play a role in determining sex ratios, likely do so through a threshold or permissive mechanism. Sex differences related to X-inactivation, imprinting, X or Y chromosome genetic modulators, and intrauterine influences, exposures, vulnerable periods, or thresholds are alternative, theoretical, explanations for sex differences of incidence.

journal_name

Autoimmun Rev

journal_title

Autoimmunity reviews

authors

Lockshin MD

doi

10.1016/s1568-9972(02)00034-4

keywords:

subject

Has Abstract

pub_date

2002-05-01 00:00:00

pages

162-7

issue

3

eissn

1568-9972

issn

1873-0183

pii

S1568997202000344

journal_volume

1

pub_type

杂志文章,评审
  • Autoantibody-induced apoptosis as a possible mechanism of autoimmune retinopathy.

    abstract::Circulating antibodies specific to retinal proteins have been associated with retinal dysfunction in patients with retinopathy. Anti-recoverin antibodies found in patients with cancer-associated retinopathy (CAR) represent a unique model to study the relationship between retinal degeneration and autoimmunity. A body o...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/s1568-9972(02)00127-1

    authors: Adamus G

    更新日期:2003-03-01 00:00:00

  • Polyarteritis nodosa: A contemporary overview.

    abstract::Polyarteritis nodosa (PAN) is a systemic necrotizing vasculitis predominantly targeting medium-sized arteries. PAN is a rare form of vasculitis, and the precise frequency of this disease is difficult to determine. The major environmental factor associated with PAN is HBV infection. The pathogenesis of "idiopathic PAN"...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2016.02.015

    authors: De Virgilio A,Greco A,Magliulo G,Gallo A,Ruoppolo G,Conte M,Martellucci S,de Vincentiis M

    更新日期:2016-06-01 00:00:00

  • Hyperhomocysteinemia, inflammation and autoimmunity.

    abstract::Hyperhomocysteinemia is independently associated with the development of coronary, cerebral and peripheral vascular disease and deep-vein thrombosis in the general population. The evidence that cardiovascular involvement is particularly frequent and advanced in patients affected with several autoimmune diseases (AD), ...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2007.03.008

    authors: Lazzerini PE,Capecchi PL,Selvi E,Lorenzini S,Bisogno S,Galeazzi M,Laghi Pasini F

    更新日期:2007-08-01 00:00:00

  • Gene therapy in autoimmune diseases: challenges and opportunities.

    abstract::Clinical treatment of autoimmune disorders presents a special challenge. For decades, most clinical regimens in autoimmunity has been largely symptomatic and non-disease specific. Although data from vigorous research has lead to accumulating knowledge on the pathogenic and immunological mechanisms of many autoimmune d...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2009.10.004

    authors: Leung PS,Dhirapong A,Wu PY,Tao MH

    更新日期:2010-01-01 00:00:00

  • Follicular helper T cells poise immune responses to the development of autoimmune pathology.

    abstract::Follicular helper T cells (T(FH)) have been implicated as a lineage that provides sufficient help to B cells in order to become professional antibody producers. This T helper subset is characterized by a distinctive cell-surface phenotype (CD4(+)CD57(+)CXCR5(+)) and cytokine profile (IL-21, IL-6, and IL-27) as well as...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2010.11.007

    authors: Gómez-Martín D,Díaz-Zamudio M,Romo-Tena J,Ibarra-Sánchez MJ,Alcocer-Varela J

    更新日期:2011-04-01 00:00:00

  • Intravenous immunoglobulin for immunomodulation of systemic lupus erythematosus.

    abstract::Intravenous immunoglobulin (IVIg) is used for replacement therapy in immunodeficiency states and for immunomodulation of various autoimmune diseases. Several case reports and series support a beneficial role of IVIg in systemic lupus erythematosus (SLE), both as salvage immunotherapy and in control of disease activity...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2005.09.002

    authors: Sherer Y,Shoenfeld Y

    更新日期:2006-02-01 00:00:00

  • Interaction of pregnancy and autoimmune rheumatic disease.

    abstract::During pregnancy, the fetus represents a natural allograft that is not normally rejected. While the maternal immune system retains the ability to respond to foreign antigens, tolerance mechanisms are up-regulated to protect the fetus from immunologic attacks by the mother. The profound immunologic adaptations during a...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2011.11.013

    authors: Østensen M,Villiger PM,Förger F

    更新日期:2012-05-01 00:00:00

  • Hashimoto thyroiditis: clinical and diagnostic criteria.

    abstract::Hashimoto thyroiditis (HT), now considered the most common autoimmune disease, was described over a century ago as a pronounced lymphoid goiter affecting predominantly women. In addition to this classic form, several other clinico-pathologic entities are now included under the term HT: fibrous variant, IgG4-related va...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2014.01.007

    authors: Caturegli P,De Remigis A,Rose NR

    更新日期:2014-04-01 00:00:00

  • Posterior reversible encephalopathy syndrome--Insight into pathogenesis, clinical variants and treatment approaches.

    abstract::Posterior reversible encephalopathy syndrome is a rare clinicoradiological entity characterized by typical MRI findings located in the occipital and parietal lobes, caused by subcortical vasogenic edema. It was first described as a distinctive syndrome by Hinchey in 1996. Etiopathogenesis is not clear, although it is ...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2015.05.006

    authors: Granata G,Greco A,Iannella G,Granata M,Manno A,Savastano E,Magliulo G

    更新日期:2015-09-01 00:00:00

  • Peripheral nervous system involvement in systemic lupus erythematosus: Prevalence, clinical and immunological characteristics, treatment and outcome of a large cohort from a single centre.

    abstract::Disorders of peripheral nervous system in patients with systemic lupus erythematosus (PNS-SLE) are a major cause of morbidity. The aims of the present study were to determine the prevalence of PNS-SLE involvement in a large cohort of SLE patients from a single centre, to characterize such involvement, treatment modali...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章

    doi:10.1016/j.autrev.2017.05.011

    authors: Toledano P,Orueta R,Rodríguez-Pintó I,Valls-Solé J,Cervera R,Espinosa G

    更新日期:2017-07-01 00:00:00

  • Is vitamin D a player or not in the pathophysiology of autoimmune thyroid diseases?

    abstract::1,25-Dihydroxyvitamin D is a steroid hormone derived from vitamin D, playing an important role in maintaining an adequate serum level of calcium and phosphorus. It is now clear that vitamin D exerts an endocrine action on the cells of the immune system, generating anti-inflammatory and immunoregulatory effects. The me...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2014.10.008

    authors: D'Aurizio F,Villalta D,Metus P,Doretto P,Tozzoli R

    更新日期:2015-05-01 00:00:00

  • International consensus: What else can we do to improve diagnosis and therapeutic strategies in patients affected by autoimmune rheumatic diseases (rheumatoid arthritis, spondyloarthritides, systemic sclerosis, systemic lupus erythematosus, antiphospholip

    abstract::Autoimmune diseases are a complex set of diseases characterized by immune system activation and, although many progresses have been done in the last 15years, several unmet needs in the management of these patients may be still identified. Recently, a panel of international Experts, divided in different working groups ...

    journal_title:Autoimmunity reviews

    pub_type: 共识发展会议,杂志文章,评审

    doi:10.1016/j.autrev.2017.07.012

    authors: Giacomelli R,Afeltra A,Alunno A,Baldini C,Bartoloni-Bocci E,Berardicurti O,Carubbi F,Cauli A,Cervera R,Ciccia F,Cipriani P,Conti F,De Vita S,Di Benedetto P,Doria A,Drosos AA,Favalli EG,Gandolfo S,Gatto M,Grembiale R

    更新日期:2017-09-01 00:00:00

  • Treatment of rheumatoid arthritis with rituximab: an update and possible indications.

    abstract::Based on new biologic and clinical insights, the number of drugs blocking different biologic targets in rheumatoid arthritis (RA) [e.g., tumor necrosis factor alpha (TNFalpha), CTLA4, interleukin (IL)-1, IL-6, IL-15, IL-18, B lymphocyte stimulator (BLyS), CD20] has increased considerably over the last decade. Rituxima...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2006.02.007

    authors: De Vita S,Quartuccio L

    更新日期:2006-08-01 00:00:00

  • Autoantibody pain.

    abstract::As autoantibodies bind to target tissues, Fc-region dependent inflammation can induce pain via mediators exciting nociceptors. But recently another possibility has emerged, where autoantibody binding to nociceptors can directly cause pain, without inflammation. This is thought to occur as a result of Fab-region mediat...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2016.02.011

    authors: Goebel A

    更新日期:2016-06-01 00:00:00

  • Anti-neutrophil cytoplasmic autoantibodies: methodological aspects and clinical significance in systemic vasculitis.

    abstract::Antineutrophil cytoplasmic antibodies (ANCA) are the serological hallmark of some idiopathic systemic vasculitides, such as granulomatosis with polyangiitis (GPA), microscopic polyangiitis (MPA) and, to a lesser extent, Churg-Strauss syndrome (CCS), the so-called ANCA-associated vasculitides (AAV). ANCA were first det...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2012.08.008

    authors: Radice A,Bianchi L,Sinico RA

    更新日期:2013-02-01 00:00:00

  • Polymerase-1 pathway activation in acute multiple sclerosis relapse.

    abstract:BACKGROUND:Increased expression of RNA polymerase 1 (POL1) molecular pathway was reported to be associated with increased disease activity in patients with multiple sclerosis (MS). However, the operating molecular mechanisms that characterize the pattern of acute MS relapse activity has not been thoroughly studied. OB...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2018.07.006

    authors: Achiron A,Zilkha-Falb R,Feldman A,Bovim M,Rozen O,Sarova-Pinhas I,Magalashvili D,Dolev M,Menascu S,Gurevich M

    更新日期:2018-12-01 00:00:00

  • Infectome: a platform to trace infectious triggers of autoimmunity.

    abstract::The "exposome" is a term recently used to describe all environmental factors, both exogenous and endogenous, which we are exposed to in a lifetime. It represents an important tool in the study of autoimmunity, complementing classical immunological research tools and cutting-edge genome wide association studies (GWAS)....

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2012.12.005

    authors: Bogdanos DP,Smyk DS,Invernizzi P,Rigopoulou EI,Blank M,Pouria S,Shoenfeld Y

    更新日期:2013-05-01 00:00:00

  • Anti-TNFalpha therapy in a cohort of rheumatoid arthritis patients: clinical outcomes.

    abstract:OBJECTIVE:To assess the effectiveness of anti-TNFalpha agents by analysing the principal clinical outcomes in patients with active rheumatoid arthritis (RA). METHODS:1010 patients who received no clinical benefit from previous treatment with methotrexate and/or other DMARDs, were subsequently treated with one or more ...

    journal_title:Autoimmunity reviews

    pub_type: 临床试验,杂志文章

    doi:10.1016/j.autrev.2008.11.001

    authors: Bazzani C,Filippini M,Caporali R,Bobbio-Pallavicini F,Favalli EG,Marchesoni A,Atzeni F,Sarzi-Puttini P,Gorla R

    更新日期:2009-01-01 00:00:00

  • The metabolic syndrome: the crossroads between rheumatoid arthritis and cardiovascular risk.

    abstract::Rheumatoid arthritis (RA) patients have an incidence of cardiovascular (CV) diseases at least two times higher than the general population. Atherosclerosis, the main determinant of CV morbidity and mortality, and carotid intima-media thickness, an early preclinical marker of atherosclerosis, also occur early on in RA....

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2011.04.018

    authors: Gremese E,Ferraccioli G

    更新日期:2011-08-01 00:00:00

  • Anti-RNA polymerase III antibodies: a marker of systemic sclerosis with rapid onset and skin thickening progression.

    abstract::Anti-RNA polymerase III antibodies (ARA) are a specific marker for Systemic Sclerosis (SSc), associated to severe disease with major organ and diffuse cutaneous involvement. In our series, ARA were found in 19 of 216 sera, in 15 cases as isolated antibodies' specificity, with a statistically negative association with ...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章

    doi:10.1016/j.autrev.2009.02.002

    authors: Cavazzana I,Ceribelli A,Airo' P,Zingarelli S,Tincani A,Franceschini F

    更新日期:2009-06-01 00:00:00

  • The role of innate immune responses in autoimmune disease development.

    abstract::Autoimmune diseases are systemic or organ-specific disorders that are the result of an attack of the immune system against the body's own tissue. Development of autoimmune disease is generally avoided by distinct mechanisms that silence adaptive self-reactive T or B cells. The innate immune system is critically involv...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2008.12.019

    authors: Waldner H

    更新日期:2009-03-01 00:00:00

  • Common variable immunodeficiency and autoimmunity--an inconvenient truth.

    abstract::Coexisting morbidities in CVID include bronchiectasis, autoimmunity and malignancies. The incidence of autoimmune disease in CVID patients may approach 20% of cases. The most common autoimmune disease found in CVID patients is autoimmune cytopenia, but rheumatoid arthritis, lupus, and now primary biliary cirrhosis hav...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2014.04.006

    authors: Xiao X,Miao Q,Chang C,Gershwin ME,Ma X

    更新日期:2014-08-01 00:00:00

  • Bisphosphonates in patients with autoimmune rheumatic diseases: Can they be used in women of childbearing age?

    abstract::Autoimmune rheumatic diseases (ARD) are prevalent in women during their childbearing age. For their treatment, high doses of corticosteroid (CS) for long-term periods are often required, increasing the risk of bone loss. According to recent guidelines, bisphosphonates (BP) should be used as first line treatment to pre...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2010.03.002

    authors: Losada I,Sartori L,Di Gianantonio E,Zen M,Clementi M,Doria A

    更新日期:2010-06-01 00:00:00

  • B-cells and mixed cryoglobulinemia.

    abstract::Mixed cryoglobulinemia (MC) is a systemic small-vessel vasculitis; B-cell expansion is the biological substrate of the disease. It can be regarded as benign lymphoproliferative condition that may evolve to frank lymphoma. HCV infection is the main causative factor of MC, as well as of other overlapping disorders, thro...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2007.02.019

    authors: Ferri C,Antonelli A,Mascia MT,Sebastiani M,Fallahi P,Ferrari D,Giunti M,Pileri SA,Zignego AL

    更新日期:2007-12-01 00:00:00

  • Novel risk factors related to cancer in scleroderma.

    abstract:OBJECTIVE:Emerging data have shown an increased risk of malignancy among patients diagnosed with systemic sclerosis (SSc) so identification of risk factors linking both disorders might have prognostic implications. The aim of this study was to assess the clinical and treatment-related risk factors for cancer in a singl...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2017.03.012

    authors: Bernal-Bello D,de Tena JG,Guillén-Del Castillo A,Selva-O'Callaghan A,Callejas-Moraga EL,Marín-Sánchez AM,Fonollosa-Pla V,Simeón-Aznar CP

    更新日期:2017-05-01 00:00:00

  • Impaired clearance of dying cells in systemic lupus erythematosus.

    abstract::Impaired clearance of apoptotic cell material has been implicated in the pathogenesis of systemic lupus erythematosus (SLE). Besides many other molecules, C1q and DNaseI contribute to an efficient clearance of dying cells. A frequently observed factor in SLE patients is the accumulation of unusually large amounts of a...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2004.10.007

    authors: Gaipl US,Voll RE,Sheriff A,Franz S,Kalden JR,Herrmann M

    更新日期:2005-04-01 00:00:00

  • Autotaxin, Pruritus and Primary Biliary Cholangitis (PBC).

    abstract::Autotaxin (ATX) is a 125-kD type II ectonucleotide pyrophosphatase/phosphodiesterase (ENPP2 or NPP2) originally discovered as an unknown "autocrine motility factor" in human melanoma cells. In addition to its pyrophosphatase/phosphodiesterase activities ATX has lysophospholipase D (lysoPLD) activity, catalyzing the co...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2016.03.019

    authors: Sun Y,Zhang W,Evans JF,Floreani A,Zou Z,Nishio Y,Qi R,Leung PS,Bowlus CL,Gershwin ME

    更新日期:2016-08-01 00:00:00

  • Potential off-label use of infliximab in autoimmune and non-autoimmune diseases: a review.

    abstract::TNF-alpha is a crucial cytokine in the establishment and maintenance of inflammation in multiple autoimmune and non-autoimmune disorders. A number of large placebo-controlled trials have shown that infliximab, a chimeric monoclonal antibody against TNF-alpha, is effective and well-tolerated in patients with Crohn's di...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2004.08.004

    authors: Atzeni F,Sarzi-Puttini P,Doria A,Iaccarino L,Capsoni F

    更新日期:2005-03-01 00:00:00

  • Influenza and pneumococcal vaccinations of patients with systemic lupus erythematosus: current views upon safety and immunogenicity.

    abstract::Systemic lupus erythematosus (SLE) is a chronic immune-mediated inflammatory multisystem disease. The onset of viral and bacterial infections may favor the exacerbation of the disease, amplify autoimmune processes and contribute to mortality and morbidity. The prevention of influenza and Streptococcus pneumoniae infec...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2013.07.007

    authors: Murdaca G,Orsi A,Spanò F,Puppo F,Durando P,Icardi G,Ansaldi F

    更新日期:2014-02-01 00:00:00

  • Autoimmunity in hepatitis C virus carriers: involvement of ferritin and prolactin.

    abstract:BACKGROUND:Ferritin and prolactin have been associated with active autoimmune diseases as systemic lupus erythematosus and autoantibody production, but have been little studied in viral infections that present autoimmunity. OBJECTIVE:To investigate the association of these two autoimmune mediators with the presence of...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章

    doi:10.1016/j.autrev.2010.10.003

    authors: Sousa GM,Oliveira RC,Pereira MM,Paraná R,Sousa-Atta ML,Atta AM

    更新日期:2011-02-01 00:00:00